Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Post-traumatic Stress Disorder01:27

Post-traumatic Stress Disorder

978
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
978
Drug Therapy01:28

Drug Therapy

449
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
449
Behavior Therapy01:22

Behavior Therapy

1.1K
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
1.1K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

706
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
706
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

977
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
977
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

2.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Top 10 Signs and Symptoms of Psychotropic Adverse Drug Events to Monitor in Residents of Long-Term Care Facilities.

Journal of the American Medical Directors Association·2024
Same author

Transcriptomic effects of rs4845604, an IBD and allergy-associated RORC variant, in stimulated ex vivo CD4+ T cells.

PloS one·2021
Same author

Sufentanil Sublingual Tablet: A New Option for Acute Pain Management.

The Annals of pharmacotherapy·2019
Same author

Pharmacogenetic analysis of belimumab fails to identify robust genetic predictors of efficacy in lupus.

Pharmacogenetics and genomics·2019
Same author

Identification of new therapeutic targets for osteoarthritis through genome-wide analyses of UK Biobank data.

Nature genetics·2019
Same author

Development and validation of the Medication Regimen Simplification Guide for Residential Aged CarE (MRS GRACE).

Clinical interventions in aging·2018

Related Experiment Video

Updated: May 4, 2026

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

6.3K

Pharmacotherapy for post-traumatic stress disorder.

Christopher P Alderman1, Linda C McCarthy, Anita C Marwood

  • 1Director of Pharmacy and Senior Clinical Pharmacist (Psychiatry), Repatriation General Hospital, Daw Park, South Australia 5041, Australia and Associate Professor, Pharmacy Practice, Quality Use of Medicines and Pharmacy Research Centre, University of South Australia, South Australia 5041, Australia. chris.alderman@rgh.sa.gov.au.

Expert Review of Clinical Pharmacology
|January 16, 2014
PubMed
Summary

Post-traumatic stress disorder (PTSD) management often requires pharmacotherapy beyond first-line nondrug treatments. Research into novel drug options and understanding individual patient genetics is crucial for effective PTSD treatment.

More Related Videos

Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity
10:43

Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity

Published on: July 1, 2014

14.1K
Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
08:25

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment

Published on: December 6, 2024

1.4K

Related Experiment Videos

Last Updated: May 4, 2026

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

6.3K
Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity
10:43

Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity

Published on: July 1, 2014

14.1K
Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
08:25

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment

Published on: December 6, 2024

1.4K

Area of Science:

  • Psychiatry and Mental Health
  • Pharmacology
  • Neuroscience

Background:

  • Post-traumatic stress disorder (PTSD) is a significant public health concern requiring effective management strategies.
  • While nondrug treatments are first-line, many patients experience residual symptoms necessitating pharmacotherapy.
  • Current pharmacotherapy primarily relies on antidepressants, particularly selective serotonin reuptake inhibitors.

Purpose of the Study:

  • To review current pharmacotherapy options for Post-traumatic stress disorder (PTSD), including adjunctive treatments.
  • To highlight the need for exploring additional pharmacologic interventions for treatment-resistant PTSD.
  • To emphasize the importance of managing comorbidities and addressing research limitations in PTSD pharmacotherapy.

Main Methods:

  • Literature review of existing research on Post-traumatic stress disorder (PTSD) pharmacotherapy.
  • Analysis of treatment modalities including nondrug therapies, antidepressants, and other drug classes.
  • Consideration of methodological limitations and biases in current PTSD research.

Main Results:

  • Selective serotonin reuptake inhibitors are the preferred initial pharmacotherapy for Post-traumatic stress disorder (PTSD).
  • Many patients require alternative or additional pharmacologic agents such as antipsychotics, anti-adrenergic drugs, anxiolytics, and anticonvulsants.
  • Management must also address common comorbidities like substance-use disorders and mood disturbances.

Conclusions:

  • Effective Post-traumatic stress disorder (PTSD) management often involves a combination of nondrug and pharmacologic approaches.
  • Further research, including pharmacogenomics, is needed to optimize future pharmacotherapy for PTSD.
  • Addressing methodological limitations in research is essential for advancing PTSD treatment.